Limberg Eye Surgery A Medical Corporation is categorized under Ophthalmologists in Templeton, CA .
Limberg Eye Surgery A Medical Corporation was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Michael Limberg at the company’s branch by writing to 959 Las Tablas Road, Templeton, California CA 93465 or by phoning (805) 925-2668. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Limberg Eye Surgery A Medical Corporation |
| Contact Person: | Michael Limberg |
| Address: | 959 Las Tablas Road, Templeton, California 93465 |
| Phone Number: | (805) 925-2668 |
| Website Address: | limberglasik.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ophthalmologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Limberg Eye Surgery A Medical Corporation was started in 0 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Michael Limberg for inquiries that concern Limberg Eye Surgery A Medical Corporation by calling the company number (805) 925-2668, as your correspondence is most welcome. Additionally, the physical location of the branch of Limberg Eye Surgery A Medical Corporation can be found at the coordinates as well as the street address 959 Las Tablas Road in Templeton, California 93465.
For its online presence, you may visit Limberg Eye Surgery A Medical Corporation’s website at limberglasik.com and engage with its social media outlets through on Twitter and on Facebook.